key: cord-1036752-k7m9e9eq
authors: Hertting, Olof
title: More research is needed on the long‐term effects of COVID‐19 on children and adolescents
date: 2021-01-04
journal: Acta Paediatr
DOI: 10.1111/apa.15731
sha: c57af7982a94065daae95ad2f44ac2ec93088442
doc_id: 1036752
cord_uid: k7m9e9eq

nan

continues to present us with new clinical challenges in all medical specialities. Signs and symptoms in infected patients have been highly variable, and some were not evident in the early phase of the pandemic. As paediatricians, the foremost finding early on was the fundamental age-dependent difference in the risk of becoming severely ill, or even modestly ill, from COVID-19. Early Chinese, Italian and US studies implied that low numbers of children were being diagnosed and that the mortality in both children and adolescents were very low. 1,2 The reason for this age difference is not yet fully understood, but it is the focus of many on-going research initiatives. 3 pandemic is too early to say. Interestingly, two of the patients in this study fulfilled the classic Kawasaki disease criteria, but both of them were included in the MIS-C group. In contrast, a joint European and American study carried out earlier in 2020 found that the MIS-C subgroup, who met the diagnostic criteria for classic Kawasaki disease, tended to be older and have higher neutrophil, C-reactive protein, ferritin, fibrinogen and troponin levels, but lower lymphocyte counts. 8 The clinical signs and symptoms reported by Carbajal et al were similar to those reported in a systematic review from September 2020, which reported that fever and gastrointestinal-related symptoms, like abdominal pain, diarrhoea and vomiting, were the most common clinical presentations. 9 The major differences between the children with MIS-C and Kawasaki disease were that the MIS-C patients were older, all of them needed of intensive care support and inotropes, they had myocardial dysfunction and displayed low lymphocytes and higher C-reactive protein levels than those with Kawasaki disease.

One current problem that needs to be addressed in studies of

College of Paediatrics and Child Health and the US Centers for Disease Control and the WHO. They only vary slightly, but the most noticeable difference is that the UK definition does not require a temporal association with clinical COVID-19 disease. It is important to note that Carbajal et al's findings were consistent, regardless of which definition they applied to their data. The scientific community needs to agree case definitions and inclusion criteria for MIS-C, to enable comparisons between different studies in the future,

Epidemiology of COVID-19 among children in China

Detection of Covid-19 in children in early

Why is COVID-19 so mild in children?

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19

The immunology of multisystem inflammatory syndrome in children with COVID-19

Multisystem inflammatory syndrome in children rose and fell with the first wave of the COVID-19 pandemic in France

Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2

Multisystem inflammatory syndrome in children: a systematic review

Paediatric chronic fatigue syndrome: 25 year perspective. Clin Child Psychol Psychiatry

How to cite this article: Hertting O. More research is needed on the long-term effects of COVID-19 on children and adolescents